A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
As part of its review, the College had planned a series of focus groups of veterinary surgeons and nurses across the UK. However, these have had to be delayed both because of social distancing rules and because of the pressures that practice teams are currently working under. However, the agency tasked with hosting the focus groups is now exploring alternative options and it is hoped there will be a revised timetable soon.
In the meantime, the College says it now plans to commission an additional independent agency to survey veterinary surgeons about their experience of remote prescribing during lockdown.
In March, RCVS Council agreed to temporarily allow veterinary surgeons to prescribe prescription-only veterinary medicines remotely, without first having physically examined the animal, subject to a number of conditions and safeguards being in place.
This position is due for review by 30th June, and the College will be looking for feedback and data from veterinary surgeons about your experience of remote prescribing, in order to determine whether these arrangements can continue, with or without any extra safeguards.
Because remote prescribing is also one of the most important aspects of the planned under care review, feedback gathered now will help inform future discussions too.
RCVS President Niall Connell said: “We recognise the current conditions that veterinary practices are working under in no way represent normal practice life. Most practices will not have been set up to offer remote services and remote prescribing in a way that they might have chosen, given sufficient time and appropriate detailed guidance, if indeed there are any future guidance changes after the review.
"However, we feel it would be remiss of us not to seize the opportunity arising from this current crisis to ask about the experiences – good or bad – of those on the frontline of clinical veterinary practice in providing remote services to their clients.
"Whilst this will be no substitute for the formal evidence gathered by the research agency in due course, whatever data and feedback we can collate from veterinary practices at this unique time for our professions will, I’m sure, be extremely valuable to our ongoing discussions."
The successful candidates, who completed their studies during 2020 and passed the examination in November, are Lucy Wilson (pictured right), from Equibreed UK, Reading, Vanessa Austin, who works at at Vets4Pets, Northampton, and Donna Johnson, the Clinical Services Manager at The Pet Vet, Barnsley.
Lucy said: “I chose to do the CVPM to cement my knowledge of how to run our practice to the best of my ability and to provide the highest level of support to my colleagues. The CVPM resources, syllabus and experience have given me a thorough understanding of my skills and areas to develop. I cannot recommend the experience highly enough.”
Chair of the VMG Certification and Training Committee, Philippa Davies, said: “The CVPM exam tests candidates’ skills in operational management, prioritising, strategy, and thinking on your feet. It’s a gruelling assessment and holders are an elite group. We are delighted to welcome Vanessa, Donna and Lucy and congratulate them on their achievement.”
For more information, visit: https://www.vetmg.com/education/cvpm/
Each SoundTalks device has a microphone which covers up to a 10-metre radius.
Noises are transmitted to the cloud where sounds are analysed using algorithms which Boehringer says use many years of data, and with the use of AI are constantly evolving.
The company says the device, which monitors coughing 24/7, has already been shown to detect respiratory disease in pigs up to five days sooner than conventional methods, allowing vets and farmers to respond quicker, improving health outcomes, and minimising the risk of infection across the herd. 1,2
Paul Thompson BA VetMB MRCVS from Garth Pig Practice said: “The earlier we can detect the onset of disease the quicker we can intervene.
"By taking action earlier we can aim to reduce morbidity and mortality, and potentially lessen treatments including antibiotic use.
"This will help improve the wellbeing of the pigs and reduce the time commitments and costs for the farmer.
"Having heard how SoundTalks is already transforming the practices of producers and vets in other parts of Europe, I am excited to use it in my own day-to-day role.
"This innovation has the potential to provide robust data as to when respiratory disease starts, allowing us to refine our prevention plans and improve the overall health of the pigs.”
www.soundtalks.com
The initiative was set up in 2014 by Mark Hirschel and Jo Amit, the co-founders of pet product company HOWND. It gained momentum last year when Ricky Gervais lent his support.
Jo said: "We have always brought our dogs Roxy and Laila to work with us, but when we moved into new offices back in 2014 we discovered that they weren’t allowed in the premises.
"This inspired us to create an event that publicised why dogs can make a positive difference in safe work environments, in attempt to encourage companies across the UK to adopt dog friendly policies.
"We’re overwhelmed with how successful Bring Your Dog To Work Day has become. It’s been amazing to see how many people have posted their dogs at work across all social media in 2014 and 2015. Most importantly, it was fantastic to raise money for a cause that has always been close to our hearts - the wonderful work of All Dogs Matter. We’re hopeful that this year will prove even more popular, building on the momentum of 2015."
The organisers point to an American study published in 2012 which concluded that dogs at work may make a positive difference by reducing stress levels in staff and increasing their levels of job satisfaction.
For more information, visit: https://bringyourdogtoworkday.co.uk
The app gives users the ability to find information on over 1000 animal medicine listings included on the compendium website; with the complete datasheets available for viewing.
The new app also allows you to scan datamatrix barcodes on veterinary medicinal product packaging to take you straight to important product information. You can also search by medication, manufacturer or GTIN.
Dawn Howard, NOAH’s Chief Executive said: "The NOAH Compendium is the recognised industry reference, and it is essential we fully utilise the information offered in the compendium with modern technology, whilst protecting the integrity and respect that it holds.
"The website, which we relaunched earlier this year, has had over 8.5 million views to date. We feel this app serves as a great addition to this modern method of accessing data – meaning users are no longer reliant on internet access to obtain the information they need.
"As an organisation, we will continue to embrace new technologies to ensure animal medicine is used correctly and responsibly in the UK. The launch of this new app goes towards ensuring all those who prescribe or use animal medicines have access to the latest technical information available for companion and farm animals when they need it."
The BVA has expressed its disappointment at a report instructed by the Welsh Government that recommends CCTV should not be mandatory in slaughterhouses in Wales.
The Safeguarding Animal Welfare at Slaughter Task and Finish Group’s report, which outlines the findings of the Group’s investigation into the welfare of animals in slaughterhouses and the potential role of CCTV, concluded that there was not a "sufficient basis" for making CCTV in Welsh abattoirs mandatory.
The BVA and the Veterinary Public Health Association (VPHA) believe mandatory CCTV in slaughterhouses and veterinary surgeons' unrestricted access to CCTV footage are vital in order to safeguard animal welfare, assist with enforcement and instil customer confidence.
Dr Neil Paton, BVA Welsh Branch President, said: "We are disappointed that the Task and Finish Group has not taken on board the concerns of vets working in slaughterhouses and not followed the logic of their own arguments about the benefits of CCTV highlighted in the report. While we know that CCTV is not the answer to all welfare concerns, it is recognised as an important tool by the Farm Animal Welfare Committee and encourages the highest standards of animal welfare and good stockmanship. We also need to ensure that where CCTV is installed, vets can have access to the footage. If there isn’t CCTV footage, or vets cannot access the footage, how can the number of reported incidents in abattoirs be verified?"
The report, The Need for and Possible Implementation of a Workable System of CCTV in All Slaughterhouses in Wales, details that only eight large abattoirs of the total 26 abattoirs in Wales have CCTV. Although the bulk of animals in Wales are slaughtered in these eight abattoirs, lack of CCTV in other abattoirs means 3.4% of poultry are slaughtered without CCTV safeguards, accounting for over 2 million birds, and 10.5% of sheep, pigs and cattle are slaughtered in abattoirs without CCTV – nearly 385,000 animals. The potential risk of welfare harm to these animals is increased by this lack of CCTV.
Gudrun Ravetz, President of the British Veterinary Association said: "What vets who work in slaughterhouses, and all those who care about animal welfare, are striving for is a culture of compassion in abattoirs. CCTV is an important tool in encouraging and implementing such a culture. The report’s recommendations encourage abattoirs to install and use CCTV effectively for training purposes, but, together with the VPHA, we would like to re-emphasise our calls for CCTV to be mandatory in all slaughterhouses in the UK and for legislation to ensure that footage is readily available to vets. We recognise that the cost of installing CCTV may be a burden for some very small abattoirs, but it is important that the animals we farm for food have both a good life and a humane death and CCTV has a key role to play in ensuring these requirements are met."
The report also outlined a number of other recommendations, which are welcomed by BVA, including the request for grants to be made available to assist small sites invest in the equipment and an additional focus on the improvement of welfare of animals during transport to slaughter.
Complete Veterinary Care (CVC) is to launch the BooBooLoon, a new alternative to the Elizabethan collar at BSAVA Congress.
According to the company, the inflatable collar offers comfort and protection advantages over old style Elizabethan collars and other devices that restrict pets from harming surgical wounds and irritating skin disorders.
The BooBooLoon, which is made in the US by a manufacturer called Headroom, will be distributed by CVC to veterinary professionals and pet shops. The collar will be available in five sizes from extra small through to extra large.
Marcy Colangelo, President of Headroom invented the device when her boxer dog Mitzi had surgery for skin cancer. She said: "I just couldn't stand leaving that cone on her. It was like putting her head in a tunnel."
Inspired by her own travel pillow, she came up with the BooBooLoon.
Marcy added: "I know the entire CVC Group administrative and veterinarian management team are enthusiastic about their upcoming BooBooLoon inflatable pet recovery collar launch. The CVC Group is very experienced and is committed to providing excellent service and quality to the veterinary profession and to independent pet shops throughout the United Kingdom."
Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.
The Cat Cabin Fever campaign will run for four weeks.
Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour. Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat. "However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment." Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR. For more information, visit: http://www.feliway.co.uk/.
CVS Group has announced that European internal medicine specialist Caroline Kisielewicz MVB CertSAM DipECVIM-CA is joining ChesterGates Veterinary Specialists with effect from 1 October 2014.
Caroline Kisielewicz graduated from University College, Dublin in 2006 and, after working in first opinion small animal practice for two years, completed an ECVIM-residency training programme at the Small Animal Hospital at the University of Glasgow in February 2013.
Most recently she has been working at the Queen Mother Hospital for Animals at the Royal Veterinary College. She is interested in all aspects of small animal internal medicine, particularly emergency medicine, transfusion medicine, immune-mediated diseases and endocrine diseases.
CVS Referral Director, Professor John Innes said: "We are delighted to welcome Caroline to our specialist team at ChesterGates. She is a rising star in internal medicine and I believe it is a measure of CVS' growing reputation for offering a diverse range of career options that we are attracting some of the strongest talent from the specialist vet pool.
"Caroline joins Ellie Mardell and Chris Saul here at ChesterGates to help us to offer an even more comprehensive and user-friendly internal medicine service."
Caroline said: "I was keen to join this excellent multi-disciplinary specialist referral hospital with its dynamic, friendly and close-knit team. Working at ChesterGates gives me the opportunity to provide the highest standard and quality of care and treatment for my patients, clients and their referring vets."
Lynda Maris, NexGard™ Spectra Product Manager said: "The campaign, which is designed to raise awareness of the rising threat from ticks, lungworm and other parasites that can endanger the health of pets and their owners, is reaching millions of pet owners."
A radio day, during which presenter Jenni Falconer and Merial vet Mike Woodhouse (pictured) discussed parasites and called on owners to visit their practice, apparently reached nearly 3 million listeners via 16 radio stations from BBC Radio Guernsey in the south, to Waves radio in Peterhead and Aberdeen.
The campaign has also been promoted with advertising on Newslink, which broadcasts to 287 stations including: Kiss, Capital, Star, Magic, Talk Sport, Classic and Absolute.
Participating practices have been send campaign support packs and Merial has provided educational and competition social media content to share on Facebook and Twitter. According to the company, its campaign Facebook page has reached reached over 1 million unique users in the last 28 days. Over the same period, Merial says 25,000 unique users have received campaign content on Twitter.
Practices can also direct clients to the campaign website www.petparasiteaction.co.uk.
Pet Parasite Action runs throughout June and July, so there's still time to get involved. For more information, contact your Merial Territory Manager, or call the company on 0870 6000 123.
Designed to help veterinary practices save clients' time and improve compliance, VetsDeliver supplies Bravecto - the company's 12 week flea and tick treatment - with the wormer of the vet's choice, by post.
Before the pandemic, practices registered clients for the service online or during an appointment and clients would have to collect the first treatments from the practice.
In response to the pandemic, however, MSD has made now it possible for clients to register from home and get their first treatments sent by post.
Amanda Melvin, Marketing Manager for Companion Animals at MSD Animal Health said: "We are all in unchartered territory and we appreciate the pressure veterinary teams are under to continue to care for their clients and local pet community.
"Many businesses are having to add new services to support online facilities and home delivery, and for vets there is also now a need to reduce footfall into practice while still generating income. Making sure effective parasite control is available will help improve compliance as temperatures rise and the risks to the health of our pets increase. It's one less thing for you and your clients to worry about."
For further information, contact your MSD Animal Health account manager or go to www.msd-animal-health-hub.co.uk/vetsdeliver.
Susan Little, pictured left, talks about ‘Low Stress Management of the Diabetic Cat’, Professor Ian Ramsey gives his: ‘Top Ten Tips on Diabetes on a Budget’, and Grant Petrie presents: ‘Patients in Lockdown’: principles to manage diabetes remotely.
John Helps, Senior Veterinary Advisor at MSD Animal Health said: “Pet diabetes continues to be of increasing importance in the UK. Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1. No-one wants to these figures rise further because of the recent challenges so the topics covered are all particularly relevant to veterinary practice teams at this time.”
To watch the presentation, use this memorable link: https://onlinexperiences.com/Launch/QReg/ShowUUID=ADB18692-C804-40FD-B8C3-5D97C7DBC333&LangLocaleID=1033.
Further information for veterinary professionals from: https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
For pet owners, the Caninsulin website offers more information about diabetes: www.caninsulin.co.uk.
The company is also working with the UK charity to call for the creation of international standards in the training and deployment of sniffer dogs.
Earlier this week, Medical Detection Dogs announced the findings of its research on scenting COVID-19, confirming that dogs can play a major role in public safety through their ability to detect the virus’ odour.
Researchers will now move to trial the dogs at sites such as ports of entry and public spaces, where dogs can screen individuals rather than samples and contribute to the fight against the virus by detecting COVID-19 carriers.
Sniffer dog schemes are currently being piloted in countries including Finland, Russia, Italy and France, but there is currently no centralised best practice process for such programmes.
Medical Detection Dogs and Purina are calling for:
Medical Detection Dogs founder and CEO Dr Claire Guest said: “Sniffer dogs have the potential to make an important contribution to the fight against COVID-19 and future pandemics. Researchers around the world are urgently working to meet that need, but it is vital that we collaborate, share the knowledge we have gained on the incredible abilities of our dogs and formalise best practice in training and deployment.
"Along with Purina we want to call for international collaboration between organisations around the world on the implementation of disease detection and research. Our vision is to guarantee that dogs are well-treated and consistent in their performance, and support the reliable, safe creation of similar schemes in developing countries, where dogs could play a huge role in halting the spread of this disease and future pandemics.”
Jeff Hamilton, CEO at Nestlé Purina PetCare EMENA, said: “Purina and Medical Detection Dogs share a belief in the positive role and impact of dogs in society. These dogs could provide fast, effective and non-invasive diagnosis and help to create safer spaces for us all, but we should ensure that each of them is trained safely, humanely and able to effectively perform their important role in detecting COVID-19."
VetTeamAMR includes a learning platform with information about responsible prescribing practises for the whole practice team, and an audit tool designed to support continuous improvements in national antimicrobial stewardship efforts.
The new companion animal materials complement the equine and farm animal resources which were launched earlier this month and in 2021 respectively.
RCVS Knowledge is launching VetTeamAMR for veterinary teams who treat companion animals at a free online event on Tuesday 20 June 2023 at 7:00 pm (BST).
The event is open to all to attend, and will include talks from:
Chris Gush, Executive Director at RCVS Knowledge said, “AMR is a hugely important issue for us at RCVS Knowledge and we are pleased to be able to provide veterinary teams with free tools and resources to support the responsible use of antimicrobials.
“Antibiotics remain the primary treatment for potentially fatal bacterial infections.
"Yet inappropriate use of antibiotics has led to resistance that has created a global animal and human health emergency.”.
“With busy veterinary practices in mind, we have worked alongside veterinary experts to create accessible and user-friendly VetTeamAMR tools and resources and we encourage all UK veterinary practices to get involved.”
To register for the online launch: https://knowledge.rcvs.org.uk/news-and-events/events/vetteamamr-companion-animal-launch-event/
Under the previous system, complaints made about a veterinary surgeon or veterinary nurse would, at Stage One, be considered by a Case Examiner Group (CEG) which would determine if there was an arguable case of serious professional misconduct.
If the CEG found there was an arguable case, it would then refer it to Stage Two of the process for consideration by the Preliminary Investigation Committee.
The CEG stage of the process has now been replaced by Stage One Preliminary Investigation Committees which, rather than using the ‘arguable case’ threshold, will consider from the outset whether there is a realistic prospect that the alleged conduct constitutes serious professional misconduct and that there is sufficient evidence.
The new Stage One Preliminary Investigation Committees will comprise members of the professions and lay people, and will be assisted in their investigations by an RCVS Case Manager who will also be the first point of contact for those raising concerns, witnesses and respondents in the case.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: “By keeping to one consistent threshold for serious professional misconduct throughout the concerns investigation process, we hope that these changes will help to simplify our investigations while still ensuring that the process remains robust and thorough.
"We also hope that, in time and when the changes are fully bedded in, we may also see a swifter resolution to some cases, as concerns that may previously been referred on to Stage Two of the process can now be closed at Stage One.”
If a Stage One Preliminary Investigation Committee cannot close a case it will refer it on to a Stage Two Preliminary Investigation Committee.
This will gather additional information and evidence and then determine if there is a realistic prospect of finding serious professional misconduct and if it is in the public interest for the case to go to Stage Three - a full, public Disciplinary Committee hearing.
Eleanor added: “The introduction of these new stages is the first step in the programme of reform of our concerns investigation and disciplinary processes.
"Next year we will be looking to introduce our Charter Case Protocol which will be a way of resolving some less serious cases of alleged misconduct where it would not necessarily be in the public interest to hold a full Disciplinary Committee hearing.”
www.rcvs.org.uk/concerns
Dechra Veterinary Products has reduced the price of two key products in its Veterinary Essentials range to help practices respond to the challenging economic climate.
Atipam 5 ml is now the same price per ml as Atipam 10ml. Used for the reversal of the sedative effects of medetomidine and dexmedetomidine in cats and dogs, practices can now choose the size that suits them best. Additionally, during January, for every 15ml purchased an extra 5ml will be provided to practices free of charge.
Thyroxyl, used for the treatment of hypothyroidism in dogs, has also been reduced in price by 15 per cent. Practices that include Thryoxyl as part of the newly introduced Essential Purchase Plan can also make further savings.
To find out more about the Veterinary Essentials range, including further costs savings with an Essentials Purchase Plan and free margin development advice, call Liz Rawlings on 01743 441632.
European veterinary practitioners are to receive guidance on the appropriate use of the fluoroquinolone group of antibiotics in treating a wide range of common diseases in companion animals.
The advice has been drawn up by the REQUEST team, a multinational and multidisciplinary group of experts which met for the third time last November. Their recommendations have been designed to help ensure the continued availability of this class of antibiotics in both veterinary and human medicine.
The REQUEST initiative aims to achieve a consensus on when and how to prescribe fluoroquinolones, based on a detailed assessment of published scientific data by its panel of nine acknowledged international experts. Following earlier meetings in Lyon and Vienna they have reached a stage in this ongoing project in which they can offer specific guidance on the use of fluoroquinolones in treating three important conditions in dogs: pyoderma, bacterial diseases of the upper respiratory tract and lower urinary tract infections. They will also be offering guidance on the appropriate use of this class of antibiotics in cats to avoid the development of retinal toxicities, which may occasionally result from treatment with one particular fluoroquinolone drug, enrofloxacin.
The guidance will be presented in papers to be submitted to those scientific journals which will be easily accessible to veterinary practitioners throughout Europe. Further papers will be produced and translated into the main European languages giving guidance on fluoroquinolones use in other important bacterial conditions in dogs and cats.
In the later stages of the project, the team will be highlighting priorities for future research and will use its influence to encourage collaborative studies involving the animal health industry, practitioners, veterinary schools and other research institutions, which will validate and redefine the current recommendations. They will also advise on studies which may provide the information needed in those clinical areas where there is currently insufficient published data on which to base any practical advice, such as the use of fluoroquinolones in minor companion animal species.
The REQUEST initiative is supported by Vetoquinol, a global supplier of fluoroquinolone medicines to the veterinary community. Further support is provided by the healthcare consultancy StratAdviser Ltd, which gives assistance on methodology and other scientific matters and also guarantees the independence of the expert group.
Companion Care Vets has reported a record calendar year in 2010, with 15 new surgeries opened taking the network up to 69.
Companion Care also welcomed 17 new joint venture partners, increasing the total number of partners to 87. The company expects to double the number of surgeries over the next 3 years following the announcement that it is to open standalone practices alongside the in-store Pets at Home surgeries.
According to the company, the opening of 15 new full service surgeries represents an investment of approximately £3 million during the year. More than £340,000 of that investment went on state-of-the-art digital x-ray imaging equipment - a feature of all new surgeries.
Managing director, Jane Balmain, said: "The in-store model has been hugely successful and we will continue to accelerate our growth plans for in-store surgeries as the Pets at Home store footprint expands.
"The launch of our new standalone division provides a solution for the vets and nurses who are looking for a partnership but whose preference is for a more traditional standalone style surgery. The level of interest since our announcement has been massive and we will be looking to capitalise on this in 2011 and beyond.
"Our vision is for Companion Care Vets to become a truly national leading veterinary group and with the record year in 2010 and our plans for 2011 and beyond, we are now well on the way and confident of achieving this."
Companion Care Vets has announced that it will open its 100th surgery in Llantrisant, South Wales on 7th September 2012.
The surgery will reside within the Pets at Home store in Llantrisant and will be owned and managed by Joint Venture Partner Rhian Bullock who has returned home to Llantristant after working and studying for many years in the USA.
Jane Balmain, Managing Director, Companion Care Vets said: "2012 has been quite a year for the business, we were named as one of The Sunday Times 100 Best Companies to Work For, becoming the first veterinary group to be awarded this accolade. Our growth has been such that we have recently launched a dedicated recruitment website, we have employed our 1,000th team member and to be opening our 100th surgery is testament to the hard work and dedication of our fantastic team."
Companion Care now has 117 Joint Veterinary Partners, 96 of whom are veterinary surgeons, 13 veterinary nurses, 7 practice managers and a receptionist and a further 953 colleagues employed by the group. The company says it has doubled in size in the past three years and is on track to do so again by 2015.
Jane said: "At present the majority of our surgeries are part of the Pets at Home in-store model but there are already five very successful standalone surgeries and the standalone surgery network plan is being developed to cater for those vets and veterinary nurses whose preference is to have a more traditional standalone surgery."
Rhian said: "A local girl, I have just moved back to Llantrisant and am really excited to be running my own practice in an area that I love. I set myself very high clinical standards and always involve the client in treatment and their pet's wellbeing. There is nothing that satisfies me more than well animals and happy clients."
Rhian and her team are involving the local community in the opening and will have guests from local branches of the Dogs Trust and the Cats Protection League present on opening day raising funds and joining in the celebrations.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References
Genitrix has repackaged its Dentagen plaque prevention chews to provide added value and convenience to pet owners.
Packs of the chews, launched in 2008 as part of Genitrix' Dentagen dental range, will now be available in 'one month' packs in response to customer feedback. The new, bigger value packs will also be priced more cost-effectively and will offer environmental benefits as the amount of packaging is reduced.
Dentagen dental chews are impregnated with a plant extract called RF2 which enables them to act as an 'anti-biofilm' treatment, modifying the membrane of oral bacteria to prevent them from producing plaque. The chews, which come in two sizes for large and small dogs, are designed to be given on alternate days and form part of the unique Dentagen Dental Care Programme. Earlier this year, Genitrix also launched Dentagen Aqua, an innovative water additive treatment to control plaque and prevent bad breath in cats and dogs.
The new size packs of Dentagen chews, which will be available exclusively through veterinary channels, cost £6.35 for a pack of 14 small chews (one month's supply) and £8.09 for 14 large chews.
Rabbit Awareness Week (RAW), which starts on 23rd May this year, is calling on veterinary practices to sign up to its free health check scheme to help raise awareness of rabbits' behavioural needs.
Participating practices will receive free support packs to help them advertise and run their health check events, as well as goodie bags to give out to clients who bring their rabbits in.
The 2011 event will see a PR, advertising and marketing campaign with backing from Burgess Excel and RAW partners, including Panacur Rabbit, Petplan Insurance, RSPCA, PSDA, The Blue Cross, Wood Green Animal Shelters and RWAF (Rabbit Welfare Association & Fund), which are the driving forces behind the RAW 2011 initiative.
Naomi Chatterley, marketing manager at Burgess Excel, said: "Following the success of last year's event, our aim is to create an even bigger success in 2011. This May, the focus is on raising awareness of rabbits' emotional welfare needs by encouraging owners to consider their rabbit's mental and emotional health. Rabbits that are not stimulated both mentally and physically tend to develop behavioral problems such as fur plucking, depression or severe aggression. Our sole aim is to educate owners about responsible rabbit ownership and improve the wellbeing of Britain's 3rd most popular pet."
If you are interested in supporting RAW 2011 by hosting rabbit healthcare clinics at your surgery, please visit http://www.rabbitawarenessweek.co.uk/ to order your free support kit and register your event.
The Royal Veterinary College has carried out the first ever open-heart surgery to treat a stenotic tricuspid valve in a dog.
The three-year-old Labrador, Mabel, suffered from congenital tricuspid dysplasia. She was referred to cardiology specialists at RVC Small Animal Referrals where her tricuspid valve was found to be completely fused in the middle, with just two very small openings for her blood to flow through.
In a procedure that took a little over an hour, the RVC team examined and worked on the valve. The College reports that Mabel’s surgery was a success and her stenosis was relieved.
Mabel was subsequently found to have a moderate amount of regurgitation into the right atrial chamber, but after a few more days of additional monitoring at the RVC she was able to return home.
The surgery was carried out by Professor of Small Animal Surgery Dan Brockman at the Queen Mother Hospital for Animals. He was assisted by a team of RVC specialists to provide pre and post-operative care, including a perfusionist, a team of three anaesthetists, two surgery nurses, three surgeons and a cardiology veterinary specialist-in-training. In addition, Professor of Veterinary Cardiology Virginia Luis Fuentes and veterinary specialist-in-training Dr Rosie Payne were members of the Cardiology Service’s investigation into Mabel’s condition.
RVC students were also involved in the Mabel’s initial examinations at the hospital, providing them with an insight into the procedure. The examinations included cardiac ultrasound using the newest generation of cardiac ultrasound equipment, which is able to capture 3D and 4D images. The new ultrasound scanner was funded in part by the RVC’s charity, the Animal Care Trust.
After the surgery, the emergency and critical care (ECC) team and the Cardiology Service took over Mabel’s care, with Professor Brockman remaining involved. This saw up to four senior ECC clinicians, a number of veterinary specialists-in-training and half a dozen highly trained ECC technicians working in shifts around the clock to care for Mabel and ensure a good recovery.
According to the RVC, there have been previous attempts by veterinary surgeons to open stenotic valves with balloon valvuloplasty. However, because it is very difficult to tear the stenotic valve, this approach has not proved very successful. There is also a high risk when putting canines onto bypass. Canines have fragile blood vessels, and cannulae need to be inserted into several of these vessels, creating a danger that a major vessel tears.
Commenting on why the RVC team decided to perform this procedure at this point, and on Mabel, Dan said: "Lots of things fed into this decision. First and foremost, we had a patient whose pathology made surgery the best solution. I explained to the owner and was very honest that this procedure would be really breaking new ground. Based on what the human paediatric cardiac surgeons will do, and our limited experience of balloon-valvuloplasty suggests this is the best approach for these dogs
"The operation itself is risky, much worse than most other operations. In our hands, for this type of disease, we have about an 80% chance of getting them through the procedure. The owner has to gamble what life the dog has left against the promise of a more normal quality of life and life-span following the operation."
In relation to Mabel’s prognosis if the surgery had not been undertaken, Professor Luis Fuentes said: "It is likely that the signs of right-sided heart failure would have been more difficult to control. Her ability to exercise would have become less and less, and she would have also been at risk of having abnormal heart rhythms associated with the enlargement of the right atrium. Generally we expect them to develop more and more signs as the disease progresses. These are difficult cases to manage on a long-term basis with drugs. Her life expectancy would have been substantially reduced.
"I thought Mabel was almost a perfect candidate to have the procedure here as Dan has a lot of experience replacing tricuspid valves in dogs with tricuspid dysplasia. In those cases there is usually leaking, but Mabel’s case was unusual in that she has minimal leaking and she was most affected by the stenosis. That means you may not have to implant any additional valve structure."
Speaking two weeks after the operation, owner Annabelle Meek, from Melton Mowbray, said: "Mabel has just come back in from wandering around the perimeter of my garden for the first time since before the operation. It’s more than half an acre and she has been ambling around happily following a scent.
"I would like to thank absolutely everybody. It’s been an enormous team effort on all sides. Every single person I met at the RVC, from the man on the gate to all the hospital staff, was so friendly. After she came home Dan Brockman phoned me every day to see how she was doing. The RVC should be very proud of what they have done for Mabel."
Drawing attention to the symptoms of allergic skin disease that owners should look out for during the warmer months, the leaflet, poster and notice board materials discuss some of the substances that dogs can be allergic to, how to manage skin allergies and what to look for in an itch prevention plan.
The materials have been produced to support Apoquel, the oral therapy for the treatment of canine pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis. They feature two dogs – Eric and Daisy – whose lives have been changed by the product.
For more information, contact your Zoetis account manager.